Open AccessEffect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial
Author(s) -
Reynold A. Panettieri,
Carlos A. Camargo,
Tariq Cheema,
Sherif G El Bayadi,
Stanley B. Fiel,
Tania M Vila,
Renu Jain,
Dawn Midwinter,
Byron Thomashow,
Andrea Ludwig-Sengpiel,
David A. Lipson
Publication year - 2022
Publication title -
international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s367701
Subject(s) - medicine , fluticasone propionate , inhaler , pulmonary disease , dry powder inhaler , exacerbation , copd , indacaterol , asthma , anesthesia , inhalation , intensive care medicine , bronchodilator
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom